|
AARS expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.92279525634831E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.43579609207723E-11 |
| Normal-vs-Stage2 |
3.10790000401795E-08 |
| Normal-vs-Stage3 |
3.49276163547074E-13 |
| Normal-vs-Stage4 |
1.695700E-02 |
| Stage1-vs-Stage2 |
1.436160E-01 |
| Stage1-vs-Stage3 |
6.785900E-02 |
| Stage1-vs-Stage4 |
1.772610E-01 |
| Stage2-vs-Stage3 |
9.064200E-01 |
| Stage2-vs-Stage4 |
3.207800E-02 |
| Stage3-vs-Stage4 |
1.960490E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.06581410364015E-13 |
| Normal-vs-AfricanAmerican |
4.380800E-03 |
| Normal-vs-Asian |
1.990630E-01 |
| Caucasian-vs-AfricanAmerican |
3.993800E-01 |
| Caucasian-vs-Asian |
8.630800E-01 |
| AfricanAmerican-vs-Asian |
8.560000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.70374825358977E-12 |
| Normal-vs-Female |
5.44010000380624E-08 |
| Male-vs-Female |
8.053700E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.404500E-03 |
| Normal-vs-Age(41-60Yrs) |
4.95669949529542E-10 |
| Normal-vs-Age(61-80Yrs) |
4.36006786230791E-12 |
| Normal-vs-Age(81-100Yrs) |
2.205900E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.438000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.152600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.636800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.505000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.830600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.740600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
5.394400E-01 |
| Normal-vs-Grade 2 |
1.63113966777928E-12 |
| Normal-vs-Grade 3 |
2.34380292951641E-11 |
| Normal-vs-Grade 4 |
6.009700E-02 |
| Grade 1-vs-Grade 2 |
2.614800E-01 |
| Grade 1-vs-Grade 3 |
3.208400E-01 |
| Grade 1-vs-Grade 4 |
8.794800E-01 |
| Grade 2-vs-Grade 3 |
5.337800E-01 |
| Grade 2-vs-Grade 4 |
1.137930E-02 |
| Grade 3-vs-Grade 4 |
3.325800E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
4.2410519540681E-14 |
| Normal-vs-ccB subtype |
7.83360043499215E-11 |
| ccA subtype-vs-ccB subtype |
9.229800E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.54969395491389E-12 |
| Normal-vs-N1 |
5.046800E-01 |
| N0-vs-N1 |
5.357900E-02 |
|
|
